Yarrow Bioscience, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveOct 7 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: RLYB, NMRA, PRLD→
From the filings
Figures
- Revenue
- $454,000last 12 months
- Net income
- −$21.5Mlast 12 months
- Operating cash flow
- −$25.7Mlast 12 months
- Cash and equivalents
- $22.9Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 668.3K shareson issue